129 related articles for article (PubMed ID: 31307224)
1. Ras-AKT signaling represses the phosphorylation of histone H1.5 at threonine 10 via GSK3 to promote the progression of glioma.
Sang B; Sun J; Yang D; Xu Z; Wei Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2882-2890. PubMed ID: 31307224
[No Abstract] [Full Text] [Related]
2. K-Ras
Zhang J; Liu W; Dong H; Wang W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2048-2057. PubMed ID: 31126199
[No Abstract] [Full Text] [Related]
3. Carcinogenic role of K-Ras-ERK1/2 signaling in bladder cancer via inhibition of H1.2 phosphorylation at T146.
Fan L; Wang Y; Wang W; Wei X
J Cell Physiol; 2019 Nov; 234(11):21135-21144. PubMed ID: 31032946
[TBL] [Abstract][Full Text] [Related]
4. Ras-ERK signalling represses H1.4 phosphorylation at serine 36 to promote non-small-cell lung carcinoma cells growth and migration.
Shi S; Zhang J; Liu M; Dong H; Li N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2343-2351. PubMed ID: 31184227
[TBL] [Abstract][Full Text] [Related]
5. Ras-PI3K pathway promotes osteosarcoma progression via regulating VRK1-mediated H2A phosphorylation at threonine 120.
Xu X; Yu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4274-4283. PubMed ID: 31810390
[No Abstract] [Full Text] [Related]
6. The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer.
Li YH; Li YX; Li M; Song SW; Ge Y; Jin JY; Li XY; Tan XD; Ye J
Life Sci; 2020 Sep; 256():117936. PubMed ID: 32531376
[TBL] [Abstract][Full Text] [Related]
7. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1.
Zhang J; Liu M; Liu W; Wang W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1207-1215. PubMed ID: 30942624
[TBL] [Abstract][Full Text] [Related]
8. KRas-ERK signalling promotes the onset and maintenance of uveal melanoma through regulating JMJD6-mediated H2A.X phosphorylation at tyrosine 39.
Li Y; Yu P; Zou Y; Cai W; Sun W; Han N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4257-4265. PubMed ID: 31736361
[TBL] [Abstract][Full Text] [Related]
9. Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16.
Wei Y; Wang F; Sang B; Xu Z; Yang D
Life Sci; 2019 May; 225():55-63. PubMed ID: 30946839
[TBL] [Abstract][Full Text] [Related]
10. K-ras-ERK1/2 down-regulates H2A.X
Dong C; Sun J; Ma S; Zhang G
BMC Cancer; 2019 May; 19(1):530. PubMed ID: 31151422
[TBL] [Abstract][Full Text] [Related]
11. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression.
An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK
BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745
[TBL] [Abstract][Full Text] [Related]
12. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
[TBL] [Abstract][Full Text] [Related]
13. FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma.
Wang C; Tu H; Yang L; Ma C; Hu J; Luo J; Wang H
Aging (Albany NY); 2021 Sep; 13(17):21587-21598. PubMed ID: 34511432
[TBL] [Abstract][Full Text] [Related]
14. K-Ras-PI3K regulates H3K56ac through PCAF to elevate the occurrence and growth of liver cancer.
Gao X; Cheng Z; Yuan H; Zhao H
J Cell Physiol; 2020 Apr; 235(4):3905-3915. PubMed ID: 31642074
[TBL] [Abstract][Full Text] [Related]
15. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
[TBL] [Abstract][Full Text] [Related]
17. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Koul D; Shen R; Bergh S; Lu Y; de Groot JF; Liu TJ; Mills GB; Yung WK
Mol Cancer Ther; 2005 Nov; 4(11):1681-8. PubMed ID: 16275989
[TBL] [Abstract][Full Text] [Related]
18. K-Ras-ERK1/2 accelerates lung cancer cell development via mediating H3
Cheng Z; Li X; Hou S; Wu Y; Sun Y; Liu B
Pharm Biol; 2019 Dec; 57(1):701-709. PubMed ID: 31613681
[No Abstract] [Full Text] [Related]
19. SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways.
Yang Y; Liang Z; Xia Z; Wang X; Ma Y; Sheng Z; Gu Q; Shen G; Zhou L; Zhu H; Xu N; Liang S
Cell Commun Signal; 2019 Jul; 17(1):82. PubMed ID: 31345225
[TBL] [Abstract][Full Text] [Related]
20. Retracted: Ras-ERK1/2 signaling promotes the development of uveal melanoma by downregulating H3K14ac.
Li Y; Sun W; Sun D; Yin D
J Cell Physiol; 2019 Sep; 234(9):16011-16020. PubMed ID: 30770563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
